A 1 billion RMB ($147 million) fund has been established by the Zhangjiang Hi-tech Zone in Shanghai to support young life science companies. Called the Zhangjiang Biopharmaceutical Industry Fund, it will assist companies with biopharmaceutical, medical device, diagnostic reagent and traditional Chinese medicine products. To qualify, the projects need to be approved for clinical trials or production/marketing, or be about to enter the clinical investigation stage. More details...